In Silico Screening, In Vitro Mpro Inhibitory, and Adjunctive Therapy Value of Minocycline for the Treatment of COVID-19
Article in Journal of Clinical Pharmacy and Therapeutics (October 2023)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Quercetin against Emerging RNA Viral Diseases: Potential and Challenges for Translation
Article (January 2023)
In silico screening of minocycline as an Mpro inhibitor and the adjunctive therapy value for the treatment of COVID-19
Preprint in Research Square (April 2022)